Romero, Maximo C.

HRN: 14-38-58  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
CO-AMOXICLAV 625MG (TAB)
03/19/2026
03/26/2026
PO
625mg
Tid
Dm Foot
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines